Poltreg S.A. (WSE:PTG)

Poland flag Poland · Delayed Price · Currency is PLN
35.90
-0.30 (-0.83%)
May 14, 2025, 12:47 PM CET
-25.98%
Market Cap 168.82M
Revenue (ttm) 350.00K
Net Income (ttm) -18.71M
Shares Out 4.66M
EPS (ttm) -4.01
PE Ratio n/a
Forward PE 181.00
Dividend n/a
Ex-Dividend Date n/a
Volume 674
Average Volume 735
Open 36.90
Previous Close 36.20
Day's Range 35.90 - 37.00
52-Week Range 33.00 - 56.80
Beta 0.98
RSI 50.44
Earnings Date Apr 17, 2025

About Poltreg

Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases. It engages in the research and development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 33
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PTG
Full Company Profile

Financial Performance

In 2024, Poltreg's revenue was 350,000, a decrease of -74.98% compared to the previous year's 1.40 million. Losses were -18.71 million, 38.1% more than in 2023.

Financial Statements

News

There is no news available yet.